Abstract
Several large randomized controlled trials (RCTs) have proven the superiority of drug eluding stents (DESs) over bare metal stents (BMSs) for native coronary stenosis. However, RCTs comparing DESs with BMSs for saphenous vein graft (SVG) lesions have predominantly been small in size and have
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
